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Body fluid homeostasis is maintained by a complex network of central and peripheral
systems that regulate blood pressure, fluid and electrolyte excretion, and fluid intake.
The behavioral components, which include well regulated water and saline intake, are
influenced by a number of hormones and neuropeptides. Since the early 1970s, it has
been known that the ovarian estrogens play an important role in regulating fluid intake in
females by decreasing water and saline intake under a variety of hypovolemic conditions.
Behavioral, electrophysiological, gene and protein expression studies have identified nuclei
in the hypothalamus, along with nearby forebrain structures such as the subfornical
organ (SFO), as sites of action involved in mediating these effects of estrogens and,
importantly, all of these brain areas are rich with estrogen receptors (ERs). This review
will discuss the multiple ER subtypes, found both in the cell nucleus and associated
with the plasma membrane, that provide diversity in the mechanism through which
estrogens can induce behavioral changes in fluid intake. We then focus on the relevant
brain structures, hypothesized circuits, and various peptides, such as angiotensin, oxytocin,
and vasopressin, implicated in the anti-dipsogenic and anti-natriorexigenic actions of the
estrogens.
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INTRODUCTION
Cardiovascular disease is the leading cause of death in women
over the age of 65 (Go et al., 2013). Because a woman’s risk of
cardiovascular disease increases around the age of menopause,
it suggests that ovarian hormones provide a protective role
(Reckelhoff, 2004; Rosano et al., 2007; Yang and Reckelhoff,
2011). Maintenance of cardiovascular health depends, at least
in part, on proper body fluid homeostasis. Water and saline
intake are two key behaviors that maintain this homeostasis. As
is common with many behaviors, there is a sex difference in
fluid intake that is largely a function of ovarian hormones. The
effects of ovarian hormones are clear from animal studies that
report changes in behavior that correspond with cyclic levels of
circulating estrogens, specifically estradiol (E2; see Figure 1 for
a summary). Laboratory animal studies have revealed influences
of ovarian hormones in rodents that have served as important
models in this field. These studies will be the focus of the majority
of this review.
The modern study of estrogens and fluid intake likely began
in 1929 when Richter and Brailey noted that female rats drank
less than males did under the same conditions (Richter and
Brailey, 1929). Although not mentioned by the authors, the data
presented from a single representative female also demonstrate
a cyclic change in water intake with lower intakes occurring
approximately every four to five days. Much of the subsequent
information about the nature of these sex differences would
come from rat studies, however, to the best of our knowledge,
the earliest report that systematically examined water intake
as a function of the ovulatory cycle was performed in 1937
using a single pig-tailed macaque (Krohn and Zuckerman, 1937).
This study found that daily water intake decreased during the
periovulatory phase, or during the time the authors described as
“sexual skin swelling,” in two of three observed menstrual cycles.
Later studies in rats confirmed that water intake fluctuates across
the estrous cycle with roughly an 8–10% reduction occurring
during behavioral estrus (Antunes Rodrigues and Covian, 1963;
Tarttelin and Gorski, 1971; Findlay et al., 1979; Danielsen
and Buggy, 1980; Eckel et al., 2000) and found that daily
water intake increases after ovariectomy (Tarttelin and Gorski,
1971).
Similar changes in saline intake, another component of proper
fluid balance, also occur in female rodents. When concentrations
of up to 2% saline are offered ad libitum, there is also a
decrease in intake during behavioral estrus (Antunes Rodrigues
and Covian, 1963; Danielsen and Buggy, 1980); however, ab
libitum intakes of higher, aversive, concentrations of saline have
been reported to be unchanged across the cycle (Findlay et al.,
1979). Hormone replacement studies in the subsequent decades
demonstrated that E2, the most prevalent circulating estrogen
in humans and rodents, is sufficient to decrease fluid intake
in ovariectomized (OVX) rodents (Spiteri et al., 1980; Jonklaas
and Buggy, 1984; Stricker et al., 1991; Scheidler et al., 1994),
whereas treatment with progesterone has no effect either on its
own or in combination with E2 (Thrasher and Fregly, 1977;
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FIGURE 1 | Estradiol (E2) secretion across the estrous cycle in the
female rat. E2 levels are low during diestrus 1 (D1), begin to rise at the end
of diestrus 2 (D2), peak in late proestrus (P), and drop to baseline levels
during estrus (E). Behavioral changes associated with estrus occur during
the dark phase, referred to here as “behavioral estrus” (shaded area).
Spiteri et al., 1980; Kisley et al., 1999b). These studies highlight
the importance of estrogens in mediating fluid intake effects, and
highlight a contrast with the control of reproductive behaviors,
which involve cooperation of effects of both estrogens and
progestins.
Because rodents are prandial drinkers, many studies of
estrogen effects on fluid intake are confounded by its anorexigenic
effect. One set of studies addressing this used OVX guinea
pigs and restriction of either food or water intakes (Czaja
et al., 1983). These experiments demonstrated that food and
water intakes can be affected by E2 independent of each other.
Additional support for an effect of estrogens on fluid intake
independent of any concomitant effects on food intake is found in
studies using dipsogenic treatment conditions during which food
intake is normally absent or minimal. A more comprehensive
review of these studies is found elsewhere (e.g., Curtis, 2009;
Xue et al., 2013), and the data seem to clearly show that
the effects of estrogens on fluid intake persist, even when
there is no potential influence of a more direct effect of food
intake.
SEX DIFFERENCES
Sex differences arise from a variety of mechanisms, occurring
at different times in development. Although studies of estrogen
effects on ingestive behavior largely focus on the behavior in
adulthood (i.e., activational effects), it is difficult to understand
these effects fully without first understanding how the brain is
organized to respond accordingly. Indeed, in adult animals, phasic
decreases in water intake are the result of fluctuations in estrogens
during the estrous cycle, but the brain must be organized in
a way that renders it capable of both generating the cycle and
responding to the cyclic hormonal signals. The primary question
here is whether or not differences in baseline or stimulated intake
are a function of different levels of circulating hormones in the
adult or different organization of the responsive nodes during
development (or both). For instance, as described above, female
rats drink less water than male rats (Richter and Brailey, 1929),
but this simple observation does not provide information about
whether this is the result of activational or organizational effects.
Studies showing decreased intake after E2 provide evidence for
an activational effect of estrogens in female rats, but the lack
of an effect of E2 in adult male rats (Jonklaas and Buggy,
1984, 1985) suggests that organizational effects also are necessary.
Consistent with many other studies of the organizational effect
of gonadal hormones, neonatal castration of male rats enables
an anti-dipsogenic response to central E2 in adulthood. In turn,
neonatal androgen treatment in female pups prevents the decrease
in fluid intake that would otherwise be caused by E2 exposure in
adulthood (Jonklaas and Buggy, 1985). As such, it appears that
both organizing and activating effects of steroid hormones play a
role in water intake.
Evaluating organizational and activational sex differences is
rather straightforward when considering the controls of water
intake, but expanding the discussion to sodium intake is a bit
more complicated. Similar to its effect on water intake, phasic E2
decreases saline intake under most conditions. These observations
differ from studies of water intake because the response does not
appear to be sexually dimorphic; unlike effects of E2 on water
intake that only occur in females, it appears that male and female
rats both decrease saline intake when treated with E2 (Stricker
et al., 1991). This argues that there is no organizational sex
difference affecting this function of E2. Paradoxically, however,
in spite of having much lower circulating estrogens, males drink
less saline under most conditions than do females (Krecek et al.,
1972; Wolf, 1982; Sakai et al., 1989; Chow et al., 1992; Flynn
et al., 1993; Curtis et al., 2004). For instance, the combination
of mild sodium deficiency and the diuretic furosemide reliably
stimulates saline intake in both male and female rats. This intake
is a function of the increased levels of angiotensin II (AngII) and
the sodium loss caused by the treatment. Although the effect
is reliable in both sexes, the saline intake observed is twice as
much when female rats are used as subjects than it is when male
rats are used (Wolf, 1982). This is true using a variety of saline
concentrations ranging from 0.5–6% and doses of furosemide
(0–10 mg). This initial study was limited, however, because it
used intact females and did not control for stage of the estrous
cycle (Wolf, 1982), but other studies demonstrate that even when
females are OVX, thereby removing the confounding issue of
the cycle, intake by the female rats is still greater than it is by
male subjects (Chow et al., 1992). Thus, whereas estrogens have
a clear anti-dipsogenic and anti-natriorexigenic effect acutely, the
higher circulating estrogens in female rats do not generate an
overall lower level of saline intake than would be predicted. As
such, it appears that there is an underlying sex difference in saline
intake that occurs separately from activational effects of ovarian
hormones.
The sex difference in baseline saline intake appears to be the
result of organizational effects of gonadal hormones. Indeed, the
sex difference in saline intake emerges early and can be observed
in pups as young as 14 days using renin treatment to stimulate
saline intake (Leshem and Epstein, 1989). Gonadectomy during
adulthood or 10 days after birth does not mitigate sex difference in
saline intake (Krecek et al., 1972; Chow et al., 1992), but castration
earlier than 10 days, during an apparent critical window, leads
to higher, female-like saline intake in adulthood. In contrast,
neonatal testosterone treatment causes females to exhibit lower,
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male-like levels of ad libitum saline in adulthood. Like many
organizational sex differences (Arnold and Breedlove, 1985; de
Vries and Södersten, 2009), this appears to require aromatization
of androgens into estrogens because DHT, a non-aromatizable
androgen, does not alter adult intake after neonatal exposure
(Chow et al., 1992). Although little is known about the specific
organizational effects that lead to these differences, altered taste
sensitivity appears to be one endpoint of these organizational
effects because taste reactivity testing and electrophysiological
recordings suggest that different gustatory sensitivity contribute
to the observed sex differences (Flynn et al., 1993; Curtis and
Contreras, 2006).
ROLE OF ESTROGENS IN THE DOUBLE-DEPLETION
HYPOTHESIS OF THIRST AND SALT APPETITE
The double-depletion hypothesis of water and salt intake, first
described by Fitzsimons (1973) and Epstein (1973) argues that
fluid intake in mammals is stimulated by alterations of either the
intracellular or the extracellular fluid compartments, that altering
the intracellular space is detected by a separable mechanism from
that which detects changes in the extracellular space, and that
the behavioral response to the dehydration of the intracellular
compartment differs from the response to dehydration of the
extracellular compartment. Intracellular dehydration, generally
caused by increased solute in the extracellular space that
dehydrates the intracellular compartment by osmosis, is detected
by osmoreceptors that are critical for the onset of fluid intake,
but the behavioral response involves consumption of water with
an apparent inhibition of saline intake. Loss of fluid from
the extracellular compartment results in hypovolemia without
affecting the concentration of the remaining fluid. Accordingly,
perturbations of this type do not engage osmoreceptive elements
of the CNS. Instead, detection of hypovolemia occurs largely by
volume receptors in the periphery; specifically by vascular and
renal baroreceptors that communicate with the CNS through
vagal afferents and by increased activity of the renin-angiotensin
system. Unlike the behavioral response to intracellular fluid loss
that selectively increases water intake, loss of fluid from the
extracellular space increases intake of both water and sodium.
The different stimuli, detection mechanisms, and behavioral
responses allow for the use of different models of fluid intake in
order to determine if things that affect the controlling elements,
for example estrogens, are selective for one or the other, or are
more general.
Estrogens appear to have minimal influence on drinking
in response to osmotic stimuli. Water intake induced by
subcutaneous hypertonic saline, for example, does not change
across the estrous cycle and is not influenced by acute or chronic
s.c., intramuscular (i.m.) or intracerebroventricular (i.c.v.) E2
treatment in OVX rats (Findlay et al., 1979; Jonklaas and
Buggy, 1984; Krause et al., 2003; Mecawi et al., 2008). There
are, however, two reports from the 1970s demonstrating that
chronic s.c. treatment of E2 decreased water intake induced
by hypertonic saline in intact cycling rats (Thrasher and
Fregly, 1977, 1978). Others using more physiologically relevant
approaches have attempted to replicate this effect, but have
had little success (Jonklaas and Buggy, 1984; Krause et al.,
2003; Mecawi et al., 2008), leading to the sense that estrogens
do not actually impact the amount of water consumed after
an osmotic challenge. Although estrogens do not seem to
influence the volume consumed under these conditions, careful
behavioral analyses have, indeed, shown subtle estrogen-mediated
differences in water intake. For example, the latency to drink
after an intravenous infusion of hypertonic saline is decreased
in OVX female rats treated s.c. with acute E2 (Jones and Curtis,
2009). A follow up study, however, showed that hyperosmolality-
induced neuronal activation in the area postrema, paraventricular
nucleus (PVN), and rostral ventrolateral medulla was decreased
in OVX female rats treated with acute s.c. E2 (Jones et al.,
2012). The authors of this study suggested that this apparent
paradox (the more rapid water intake in the face of a
reduced neural response) may reflect either a disinhibition of
water intake or a function of changes in a central pressor
response. Indeed, increases in blood pressure inhibit fluid intake
(Klingbeil et al., 1991; Thunhorst et al., 1993) and estrogens
have hypotensive effects in a number of systems (Bachmann
et al., 1991). Accordingly, it seems equally plausible that the
more rapid water intake is caused by E2-induced changes in
cardiovascular tone. Nevertheless, it seems clear that estrogens
can play at least an indirect role in water intake after osmotic
stimuli.
Estrogens have a more pronounced and clearer role in
hypovolemic fluid intake. Because engagement of the renin-
angiotensin system is a common feature of models of
hypovolemia, injections of AngII are often used to study
hypovolemic fluid intake. Intakes of both water and saline
stimulated by i.c.v. AngII vary across the estrous cycle with lowest
intakes on the day of estrus (Findlay et al., 1979; Danielsen and
Buggy, 1980). This is, however, dependent on the concentration
of saline provided and seems to be more observable using more
palatable concentrations of saline; for example, intake of 1.8%
saline was affected by cycle stage, but intake of 2.7% saline was
not (Findlay et al., 1979; Danielsen and Buggy, 1980). A cyclic
change alone does not demonstrate a role for estrogens in this
observation, but several additional findings strongly support it
being dependent on ovarian estrogens. First, the cyclic changes
in i.c.v. AngII-stimulated intakes are lost after OVX (Findlay
et al., 1979). Second, E2 treatment (chronic or acute s.c., or
acute i.c.v.) dose-dependently decreases fluid intake after AngII
(i.c.v. or intraperitoneal ;i.p.) in OVX rats (Fregly, 1978; Fregly
and Thrasher, 1978; Jonklaas and Buggy, 1984; Kisley et al.,
1999b). Third, the effect of E2 is blocked by administration of
an antiestrogen (Kisley et al., 1999b). Unlike some estrogen-
dependent behaviors, progesterone does not appear to modify
these effects of E2 (Thrasher and Fregly, 1977; Spiteri et al., 1980;
Kisley et al., 1999b). Accordingly, the data strongly support a role
for endogenous estrogens, most likely attributable to E2, in the
control of saline intake.
Although AngII has been used to model hypovolemia, the
response to true hypovolemia involves more than a simple rise
in AngII activity. Accordingly, before concluding that estrogens
affect hypovolemia-induced fluid intake, we must consider other
models of hypovolemia. Indeed, data using other ways to model
hypovolemia corroborate the role of estrogens in hypovolemic
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fluid intake. For instance, fluid intake after treatment with the
β-adrenergic agonist isoproterenol is decreased by estrogens.
Cyclical variations in isoproterenol sensitivity are found across
the estrous cycle, with the lowest isoproterenol-induced intake
observed during estrus (Kucharczyk, 1984). Either E2 treatment
(acute or chronic s.c.) decreases water and saline intake stimulated
by isoproterenol in OVX rats (Thrasher and Fregly, 1977, 1978;
Fregly, 1978; Krause et al., 2003; Jones and Curtis, 2009). Thus,
drinking after β-adrenergic agonist treatment appears to be
subject to the same influence of estrogens as is drinking after
AngII and these findings can be further generalized to other
models of hypovolemia. Water and saline intakes stimulated
by treatment with the diuretic furosemide, either alone or
in combination with captopril, are less robust on the day
of estrus than they are when the treatments are given on
diestrus. Moreover, intake stimulated using this treatment is
decreased by s.c. E2 in OVX rats (Mecawi et al., 2008; Dalmasso
et al., 2011). Chronic s.c. E2 treatment also decreases water
intake stimulated by renin-treatment in OVX rats (Thrasher
and Fregly, 1977). Finally, water restriction or maintenance
on a sodium deficient diet stimulates less intake when OVX
rats are treated with acute or chronic s.c. E2 than it does
without E2 (Stricker et al., 1991; Krause et al., 2003; Mecawi
et al., 2008). In contrast to the more nuanced and subtle
effects of estrogens on water intake after osmotic stimuli, the
effects of estrogens on hypovolemic fluid intake are more
clear.
ESTROGEN RECEPTORS
Estrogen receptor (ER) is classically described as a nuclear
receptor that acts as a ligand-dependent transcription factor. The
initial view that this occurs through a single receptor type has
been expanded to include two nuclear receptors, ERα and ERβ.
Indeed, estrogens binding at ERα and/or ERβ cause the formation
of hetero- or homodimers of these receptor proteins and initiates
recruitment of coactivators /corepressors that increase or decrease
transcription (O’Lone et al., 2004; Heldring et al., 2007). The
classical view has been further expanded by the identification
of novel estrogen binding sites more closely associated with or
embedded in the cell membrane. Novel proteins responsible for
a subset of these membrane-associated binding sites have been
identified and named GPR30, ERX, and Gq-mER and there is
now documentation that both ERα and ERβ can localize to the
plasma membrane and act as surface receptors (Micevych and
Dominguez, 2009; Micevych and Kelly, 2012). When activated
by estrogens, these receptors stimulate intracellular signaling
cascades that can change the excitability of neurons through the
rapid activation of kinases and increases in calcium. In addition,
these receptors influence gene expression though intracellular
signaling cascades that activate transcription factors such as
cAMP response element binding protein (CREB; Vasudevan and
Pfaff, 2007; Micevych and Dominguez, 2009). As such, there are
several mechanisms through which estrogens can act and means
to affect gene expression.
There are ERs in all brain regions implicated in the control
of fluid intake although not all nuclei express each ER subtype
(Shughrue et al., 1997; Shughrue and Merchenthaler, 2001;
Brailoiu et al., 2007). For example, ERα appears to be the
only subtype expressed in the subfornical organ (SFO) whereas
ERβ and GPR30, but not ERα, are expressed in the PVN and
supraoptic nucleus (SON; Shughrue et al., 1997; Shughrue and
Merchenthaler, 2001; Brailoiu et al., 2007). To date there have
been very few studies examining the roles of ER subtypes in fluid
intake in female subjects.
ER SUBTYPES AND FLUID INTAKE
Attempts to determine the role of individual ER subtypes in
fluid intake have been complicated by the variety of receptors
(ERα, ERβ, GPR30, etc.) and their cellular distribution (nuclear
vs. membrane-associated). Our laboratory has started to address
this question empirically. As a first step, we tested for intake
effects of membrane-associated ER subtypes. These studies rely
on information from others showing that estrogen effects on
fluid intake often take hours or days to become observable after
the treatment (Kisley et al., 1999b; Krause et al., 2003). In a
study specifically designed to test for the rapid behavioral effects
of acute s.c. E2 on fluid intake, there was no change in short
term (15 min) water intake stimulated by isoproterenol in OVX
rats. The earliest observable effects of E2 were not apparent
until 24 h after treatment (Graves et al., 2011). The delayed
response is consistent with a genomic effect of estrogens, but,
as described above, either direct action of nuclear ER or indirect
action of membrane ER can influence gene transcription. As such,
we performed experiments to determine if the observed effects
involved only nuclear receptors or if membrane ER subtypes
play a role. Specifically, we treated OVX rats i.c.v. with an E2-
BSA conjugate, which cannot enter the cell and is therefore
limited to activating membrane receptors, and found decreases
in overnight water intake (Santollo et al., 2013). Furthermore,
analysis of licking patterns suggests that E2 effects on intake are
due to changes in both post-ingestive and orosensory aspects of
water intake, but when only membrane ER was activated, the
decrease in water intake was mediated only by a change in post-
ingestive signals. This suggests that membrane ER is involved in
modulating satiety signals associated with water intake and the
difference in the effects of E2 and the E2-BSA argues that the
different populations of ER (membrane-associated and nuclear)
play separable roles in controlling fluid intake. Although these
studies support a role for membrane-associated ER subtypes in
the control of overnight water intake, they do not identify a
specific subtype involved. In addition, it is possible that the ER
populations mediating E2’s anti-dipsogenic effect on overnight
water intake are different from the ER populations mediating its
effect on stimulated water intake. Indeed, ongoing and future
studies will be important to address these questions and gain a
better understanding of the role of ER subtypes in the control of
fluid intake.
FLUID BALANCE AND ER EXPRESSION
Although the estrogens appear to primarily affect fluid intake after
hypovolemic challenges, perturbations of either intracellular or
extracellular fluid compartments appear to affect ER expression.
Major changes in ERα and ERβ expression are highlighted here
but for an in depth review please see Somponpun (2007). For
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instance, ERβ mRNA in the SON is increased by salt-loading
and decreased by hypo-osmolality caused by s.c. infusions of
the vasopressin analog, 1-desamino-[8-D-arginine] vasopressin
(Somponpun and Sladek, 2003). Similarly, ERβ is decreased in
both the SON and PVN after 48 h water deprivation (Somponpun
et al., 2004b) and after polyethylene glycol-induced hypovolemia
(Somponpun and Sladek, 2004). Interestingly, ablations of the
anteroventral third ventricle region (AV3V) eliminate the effect
of water deprivation in the SON, but not the PVN (Somponpun
et al., 2004b). Although the effects in these studies were
selective to ERβ, other work has shown water deprivation-induced
increases in SFO ERα (Somponpun et al., 2004a). Unfortunately,
to the best or our knowledge, all published studies examining
these effects to date have used male rats, so the relevance to the
anti-dipsogenic and anti-natriorexigenic responses to estrogens
in females is unclear. Future studies will be important to test
for any sex differences in the response and to test for causal
relationships between the changes in receptor expression and
behavior.
HYPOTHALAMIC SITE OF ACTION
Studies examining behavioral and electrophysiological responses
to AngII have identified multiple hypothalamic nuclei and nearby
forebrain structures that are important for anti-dipsogenic and
anti-natriorexigenic effect of estrogens. Included in this list are
the SFO, lateral hypothalamus (LH), PVN, SON, median preoptic
area (MnPO), medial preoptic area (mPOA), and organum
vasculosum of the lamina terminalis (OVLT). Importantly, at
least one ER subtype is expressed in each of these brain areas
and many express more than one type of ER (Shughrue et al.,
1997; Shughrue and Merchenthaler, 2001; Brailoiu et al., 2007).
Additionally, sites such as the SON, that do not express certain
ER subtypes, specifically ERα, can respond to the relevant
signals through projections from ERα-expressing neurons in
surrounding nuclei (Voisin et al., 1997).
There is ample data demonstrating that the SFO plays a major
role in the dispogenic effect of E2 via projections to, and input
from, other hypothalamic nuclei. AngII injection directly into the
SFO stimulates water intake that can be attenuated by chronic
s.c. E2 treatment in OVX rats (Fujisawa et al., 2001; Tanaka
et al., 2002, 2003). Co-localization of ERα and angiotensin type
1 receptor (AT1R) in SFO neurons provides further evidence for
the SFO as an important site of action (Rosas-Arellano et al.,
1999). This hypothesis is additionally supported by studies of
neural activity. For instance, in OVX rats the effect of intra-
carotid AngII on neurophysiological recordings of SFO neurons
is attenuated by chronic s.c. E2 treatment (Ciriello and Roder,
2013) and isoproterenol-induced Fos-immunoreactivity in the
SFO is decreased by acute s.c. E2 treatment (Krause et al.,
2006).
Although the SFO is a strong candidate structure for an
interaction between AngII and estrogens, it clearly does not act
in isolation and is, instead, part of a broader distributed circuit
in the hypothalamus. Relevant connections between the SFO and
the LH, PVN, and MnPO appear important for the mediation of
anti-dipsogenic effects of estrogens. For instance, in OVX rats LH
injections of AngII stimulate water intake and this is attenuated by
chronic s.c. E2 (Fujisawa et al., 2001). This effect likely involves the
efferent projections to the SFO (Lind et al., 1984) because water
intake stimulated by AngII treatment in the LH is attenuated by
pretreatment with an angiotensin receptor antagonist, saralasin,
in the SFO. Water intake was further attenuated in OVX rats
treated with chronic s.c. E2, suggesting that AngII-responsive
neurons that project from the LH to the SFO are inhibited by
E2 (Fujisawa et al., 2001). Furthermore another study in OVX
rats demonstrated that SFO neurons showed less excitation after
iontophoretically applied AngII and electrical stimulation of the
LH after chronic s.c. E2 treatment compared to controls (Tanaka
et al., 2001).
Behavioral and electrophysiological studies demonstrate that
the PVN acts downstream of the SFO in mediating an anti-
dipsogenic effect of estrogens. Water intake stimulated by AngII
treatment in the SFO was attenuated by pretreatment with the
AngII antagonist saralasin into the PVN. Water intake was further
attenuated in OVX rats that were treated chronically with s.c.
E2 (Tanaka et al., 2002). Furthermore, in OVX rats acute s.c.
E2 has been reported to decrease spontaneous firing rate and
increase the absolute refractory period in SFO neurons which
have been antidromically activated by electrical stimulation of
the PVN (Tanaka et al., 2001). In this same study, acute s.c.
E2 treatment in OVX rats decreased AngII stimulated neuronal
excitation of PVN activated SFO neurons (Tanaka et al., 2001).
Similar studies demonstrated that pretreatment with saralasin in
the MnPO decreased water intake stimulated by AngII-treatment
in the SFO, which is further attenuated by chronic s.c. E2
treatment in OVX rats (Tanaka et al., 2003). Finally, in OVX rats
there is a decrease in neuronal firing after AngII in SFO neurons
antidromically activated by SON stimulation after treatment with
chronic s.c. E2 (Ciriello and Roder, 2013). Taken together these
data show that the SFO, LH, PVN, MnPO and SON are all
part of the estrogen-sensitive circuitry that are involved in fluid
intake.
In addition to the brain regions highlighted above that have
been studied with respect to their connections with the SFO, the
mPOA and OVLT also appear to be involved in mediating anti-
dipsogenic and anti-natriorexigenic effects of estrogens, perhaps
independent of any connections these structures have with the
SFO. AngII injections directly into the mPOA stimulate water
intake and this is attenuated on the day of estrus (Kucharczyk,
1984). This may be, at least in part, due to direct effects of
estrogens on mPOA neurons because acute E2 injections directly
into the mPOA of OVX rats decrease water intake stimulated
by lateral ventricle injections of AngII (Jonklaas and Buggy,
1985). Indeed, this finding could be seen as evidence that some
of the effects of less focused treatments with E2 act at the
mPOA to reduce intake. Similarly, E2 injection directly into
the region that comprises the front wall of the third ventricle
decreases both AngII-stimulated and overnight water intake in
OVX rats (Jonklaas and Buggy, 1984); however, this effect is
likely more specific to cells in the OVLT than in the rest of the
ventral lamina terminalis because intake after AngII injections
directly into the MnPO, which lies dorsal to the OVLT, is not
influenced by chronic s.c. E2 treatment in OVX rats (Tanaka et al.,
2003). Natriorexigenic treatments such as furosemide increase the
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FIGURE 2 | Summary of estrogen effects on AngII-sensitive neural
circuits. The illustration summarizes the findings reviewed here regarding the
specific hypothalamic connections that are affected by both estrogens and
AngII. The different colors represent the primary ER subtype expressed in a
given structure (ERα, blue; both ERβ and GPR30, red; both ERα and ERβ,
purple). Structures in which AngII can act directly to stimulate water intake
are highlighted by a yellow border around the label. The lack of a connection
or a site of action depicted should not be viewed as evidence for the absence
of any projection or effect, but simply reflects the lack of experimental
support for its existence.
number of Fos-positive cells in the OVLT and the magnitude
of this effect is attenuated in rats during estrus. Surprisingly,
the magnitude of the effect is also attenuated in OVX rats, even
though the predicted effect of OVX would be the opposite of what
is observed. Furthermore, acute s.c. E2 treatment in OVX rats
completely eliminated the furosemide-induced increase in Fos in
the OVLT (Dalmasso et al., 2011). Importantly, these responses
seem to be anatomically selective because chronic E2 infusion
into the ventromedial hypothalamus (VMH) of OVX rats does
not change i.c.v. AngII-induced water intake (Jonklaas and Buggy,
1985), even though the VMH contains dense ER expression
(Shughrue et al., 1997). Together these studies demonstrate an
involvement of multiple hypothalamic nuclei in mediating anti-
dipsogenic/anti-natriorexigenic effects of estrogens (summarized
in Figure 2).
ESTROGEN-PEPTIDE INTERACTIONS
Localization of the action of estrogens provides clues into
the possible mechanism(s) underlying the anti-dipsogenic/anti-
natriorexigenic effect. Because the hypothalamus and nearby
structures are sites where estrogens influences fluid intake, the
neuropeptides that act or are expressed in these areas are possible
targets of estrogens. Indeed, a number of peptides and their
receptors in these areas are influenced by estrogens and this likely
contributes to these changes in fluid intake. Without attempting
to generate an inclusive list, three peptide systems that are
important for fluid homeostasis are highlighted here.
ANGIOTENSIN
Many studies described already in this review have shown a
clear effect of estrogens on AngII-induced fluid intake. Based
on this interaction, additional studies have investigated changes
in the angiotensin receptor, specifically the AT1R, as a potential
mechanism for the observed behavioral changes. Indeed, in OVX
rats acute s.c. E2 decreased AngII binding in large blocks of
tissue that included the thalamus, septum and preoptic area,
without any observable change in tissue blocks that included the
hypothalamus, midbrain or olfactory area (Jonklaas and Buggy,
1985). The anatomical locus of this change was refined by later
studies to include acute s.c. E2-induced changes in AT1R in
the SFO, but no changes in the OVLT, MnPO, suprachiasmatic
nucleus, SON, PVN or median eminence were found (Kisley
et al., 1999a). Studies that removed endogenous estrogens by
OVX supported the previous results by showing OVX-induced
increases in AT1R binding in the SFO, and also found increases
in the SFO, PVN and MnPO (Dean et al., 2005). Whether the
change in binding is a function of altered receptor affinity or
downregulation of the receptor remains unclear, but decreased
AT1R mRNA in relatively large blocks of tissue was also reported
in one study (Kisley et al., 1999a), suggesting a primary effect
on receptor availability. The questions asked by these studies
have been revisited recently using more refined approaches that
examined AT1R expression and binding in discrete nuclei in OVX
rats and found a decrease in AT1R mRNA after acute s.c. E2
treatment in the SFO and a decreases in AT1R binding in the
SFO, OVLT, PVN and MnPO after chronic s.c. E2 treatment
(Dean et al., 2005; Krause et al., 2006). It is important to
note that in the study by Krause et al. weight loss caused
a reduction in AT1R expression in the SFO and a reduction
in the dipsogenic response, both of which were reduced by a
similar magnitude as the decrease caused by E2 (Krause et al.,
2006). Accordingly, it remains unclear if the observed change in
AT1R expression is secondary to the weight loss caused by E2
treatment. Regardless of the more proximal cause, these studies
provide strong support that estrogens decrease both binding and
expression of AT1R. The complete story is further complicated,
however, by reports of increased angiotensin binding and/or
mRNA in the locus coeruleus, MnPO, SFO and ARC when
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OVX rats were given acute s.c. E2 and progesterone (Donadio
et al., 2005, 2006). Based on these data, one might conclude that
E2 alone is quite different in its effects from the combination
of E2 and progesterone, but the behavioral relevance of this
finding would be questionable because studies of progesterone
effects in fluid intake have not revealed any obvious contribution
(Thrasher and Fregly, 1977; Spiteri et al., 1980; Kisley et al.,
1999b).
In addition to effects on AT1R, estrogens also influences other
parts of the renin-angiotensin system. Many of these effects
occur in the periphery and are, therefore, outside the of the
present focus on the CNS (for review of these changes, please
see Kuroski de Bold, 1999; Fischer et al., 2002), but the more
recent recognition of a central renin-angiotensin system (for
review, see McKinley et al., 2003), offers an important target for
future investigation. Indeed two recent studies demonstrate that
angiotensin converting enzyme (ACE) expression and binding
in the lamina terminalis increases after OVX with acute i.c.v. or
chronic s.c. E2 replacement (respectively) restoring levels to those
observed in intact females (Dean et al., 2005; Xue et al., 2014).
Future studies are required to further investigate these changes
and to isolate components of the central renin-angiotensin system
as a target of estrogens.
OXYTOCIN
Oxytocin inhibits saline intake and appears to act as a brake
to prevent saline intake when water intake is stimulated by
intracellular dehydration (Blackburn et al., 1992, 1993). This is
an important function because saline intake during intracellular
dehydration would further exacerbate the deficit, and why it is
physiologically important that the effect of oxytocin is limited to
saline intake and does not generalize to water intake (Blackburn
et al., 1992, 1993). The mechanism of this inhibition is unclear,
but some clues may arise from early studies of reproductive
behaviors and the interactions between oxytocin and estrogens
in hypothalamic regions such as the VMH (Ivell and Walther,
1999). In cycling female rats, oxytocin receptor (OTR) expression
in the VMH fluctuates with the estrous cycle and is at the highest
level during proestrus (Bale et al., 1995a). Acute s.c. E2 increases
OTR expression in the VMH and increases OTR binding in OVX
rats (Bale and Dorsa, 1995; Bale et al., 1995b). Estrogens also
affect the oxytocin system in structures known to be involved
in fluid homeostasis. Multiple studies have demonstrated that
oxytocin mRNA and immunoreactivity in the SON and PVN are
increased by chronic s.c. E2 treatment of OVX rats (Jirikowski
et al., 1988; Caldwell et al., 1989; Crowley et al., 1995). A later
report in OVX rats, however, showed that oxytocin mRNA in
the PVN is decreased after E2 treatment, whereas expression
was unchanged in the SON (Shughrue et al., 2002). The latter
study used a single acute injection of E2, making the different
results potentially reflective of differences in the duration of
E2 action (Shughrue et al., 2002). Nevertheless, these changes
are likely mediated by either ERβ or GPR30 because double-
labeling approaches reveal co-expression of these proteins in
cells in both the PVN and SON (Hrabovszky et al., 1998;
Shughrue et al., 2002; Brailoiu et al., 2007; Sakamoto et al.,
2007).
In addition to more direct estrogen-induced changes in
oxytocin or its receptors, the ability of other stimuli that normally
affect oxytocin, such as an osmotic challenge, is affected by
estrogens. Specifically, treatment with hypertonic saline increases
plasma oxytocin during the late afternoon of estrus and diestrus,
and E2 enhances the increase in plasma oxytocin after hypertonic
saline exposure in OVX rats. On the other hand, oxytocin
in the PVN is increased by hypertonic saline administration
during proestrus, but not during diestrus or estrus (Caligioni
and Franci, 2002), arguing that the measures of plasma and
PVN oxytocin are not necessarily consistent. Interpretation of
some of these results is clouded by overlapping and inconsistent
nomenclature, however, presenting the possibility that many
of the things said to occur during proestrus are actually
occurring during what we refer to as behavioral estrus (for
review of this nomenclature issue, please see Becker et al., 2005).
Nevertheless, the concept that oxytocinergic tone is increased
by estrogens, and the evidence for inhibition of saline intake
by oxytocin, are collectively consistent with the hypothesis that
estrogens decrease saline intake, at least in part, by increasing
activity in oxytocin responsive neurons. Other studies, however,
complicate this otherwise parsimonious explanation. As noted
above, estrogens have only subtle effects on ingestive responses
to intracellular (osmotic) stimuli, but oxytocin is part of the
response to osmotic perturbation and oxytocin is affected by
estrogens. If any oxytocin that participates in the control of
fluid intake is similarly affected, then OVX should have a
noticeable effect on the behavioral response to hypertonic saline.
As such, the relevance of oxytocin and its interactions with
estrogens remain poorly understood factors in the control of fluid
intake.
VASOPRESSIN
Although vasopressin does not influence fluid intake directly, its
secretion is stimulated in parallel with fluid intake and it is clearly
critical in the maintenance of body fluid homeostasis (Daniels
and Fluharty, 2009). Given the effects of estrogens on fluid intake,
and that ER subtypes are expressed within vasopressin expressing
neurons (Hrabovszky et al., 1998, 2004; Brailoiu et al., 2007),
it may not be surprising to find concurrent effects of estrogens
on the vasopressin system. The literature, however, is full of
conflicting reports of sex differences in the vasopressin system
and the relevant effects of estrogens (for review, please see Sladek
and Somponpun, 2008). Whereas some have not found E2-
related changes in blood vasopressin by E2 (Crofton et al., 1985;
Wang et al., 1996), others have reported that baseline levels of
vasopressin increase during early proestrus in intact rats (Skowsky
et al., 1979). The differences in these reports could be due to the
specific timing of the obtained measurements and the light cycles
used by the investigators. Other studies have found that removal
of endogenous estrogens by OVX decreases blood vasopressin
(Peysner and Forsling, 1990) and that circulating vasopressin is
increased by low doses of s.c. E2 but decreased by high doses
of s.c. E2 (Skowsky et al., 1979; Peysner and Forsling, 1990).
The increase in vasopressin mediated by the lower doses of E2
is consistent with electrophysiological recordings finding that
chronic s.c. E2 doubles the discharge rate of vasopressin secreting
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neurons in the SON of OVX rats (Akaishi and Sakuma, 1990),
but studies using hypothalamo-neurohypophyseal explants found
that vasopressin release stimulated by glutamate agonist or
hypertonic conditions is inhibited after bath application of E2
(Swenson et al., 1998). In light of the seemingly conflicting
results, it seems especially important to consider the effects in
the whole animal. Indeed, studies of this nature find that OVX
reduces the pituitary vasopressin release and expression that is
normally stimulated by either osmotic or hypovolemic challenges
and that this reduction is prevented by acute or chronic s.c. E2
replacement (Crowley and Amico, 1993; Hartley et al., 2004).
This is consistent with the finding that acute s.c. E2 increases
i.c.v. AngII-induced Fos expression in PVN vasopressin neurons
of OVX rats (Kisley et al., 2000). Accordingly, the data from
these studies suggests opposite effects of estrogens on fluid intake
and the vasopressin system. It is tempting to speculate that the
opposite direction of the effects (E2 decreasing intake while often
increasing vasopressin) reveals an interesting way that the system
can maintain homeostasis in the face of decreased fluid intake.
While intake is reduced by estrogens, diuresis is simultaneously
reduced by the increases in vasopressin, allowing the animal to
drink less and still maintain adequate hydration. This is coupled
with an increase in the anti-diuretic potency of vasopressin in
females during estrus (Wang et al., 1995). Thus, these systems
appear to respond to estrogens in opposite directions to maintain
homeostasis.
CONCLUDING REMARKS
Estrogens have obvious effects on behavior and health and
regulation of fluid intake is particularly critical for cardiovascular
health. In addition to this more direct translational relevance,
studies of estrogens on fluid intake serve as an important basic
model for understanding broader questions related to behavioral
effects of steroid hormones and steroid-peptide interactions. This
review has focused on previous studies examining the effects of
estrogens on water and salt intakes, and clearly demonstrates the
sparsity of studies in this area while highlighting the many open
questions that remain. It is especially notable that many studies
in this subfield use only male subjects and often make erroneous
assumptions that the conclusions drawn from these studies can be
extended to females. Indeed, direct comparisons have repeatedly
revealed striking contrasts. This issue is additionally complicated
by the discrepancies that can arise when attempting to translate
basic research to clinical application. This is not to say that a
translational approach is impossible. Indeed, there are studies
demonstrating cycle-related changes in fluid balance in humans.
For example, the amount of hypertonic saline needed to stimulate
water intake decreases in women during the luteal phase, (Vokes
et al., 1988) (for recent reviews of the human literature, see
Stachenfeld, 2008; Wenner and Stachenfeld, 2012), but further
studies are needed, both at the basic and translational levels. We
are cautiously optimistic, however, that the recent strategic plan
of the National Institutes of Health (Pinn et al., 2010) will help to
address these important issues.
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